Supriya Lifescience Limited (NSE:SUPRIYA)
India
· Delayed Price · Currency is INR 788.00
+56.20 (7.68%)
Apr 2, 2025, 3:29 PM IST
Supriya Lifescience Revenue
Supriya Lifescience had revenue of 1.86B INR in the quarter ending December 31, 2024, with 32.54% growth. This brings the company's revenue in the last twelve months to 6.71B, up 20.94% year-over-year. In the fiscal year ending March 31, 2024, Supriya Lifescience had annual revenue of 5.70B with 23.74% growth.
Revenue (ttm)
6.71B
Revenue Growth
+20.94%
P/S Ratio
8.79
Revenue / Employee
14.97M
Employees
448
Market Cap
58.90B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 516.03B |
| Divi's Laboratories | 90.78B |
| Cipla | 267.20B |
| Mankind Pharma | 116.41B |
| Apollo Hospitals Enterprise | 211.46B |
| Zydus Lifesciences | 222.47B |
| Aurobindo Pharma | 309.22B |
| Alkem Laboratories | 127.57B |